Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-12-19

Clinical Trial Update: Pre-operative Pregabalin and Ketamine to Prevent Phantom Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating pre-operative pregabalin and ketamine for preventing phantom pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Pregabalin (Pregabalin)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Phantom Pain | Phase 3 | Status: WITHDRAWN